Get In Touch

Tumor that arises from specialized body cells, called neuroendocrine cells, is known as neuroendocrine tumor. Neuroendocrine tumor arises from cells that produce hormones; thus, it  produces and releases hormones into the blood in response to signals received from the nervous system. It can occur anywhere in the body, but most commonly occurs in pancreas, digestive tract, lungs, rectum, and appendix. Neuroendocrine tumor can be either benign (non-cancerous) or malignant (cancerous). Types of neuroendocrine tumors are islet cell tumors, carcinoid tumors, pheochromocytomas, medullary thyroid cancer, neuroendocrine carcinoma, and others. Neuroendocrine tumors are a rare kind of tumor. It is estimated that more than 12,000 people are affected by neuroendocrine tumors each year in the U.S. Growing prevalence of neuroendocrine tumors is expected to drive the growth of the market during forecast period. In addition to it, significant increase in funding by various international organizations, such as, the World Health Organization and the American Cancer Academy is projected to boost the neuroendocrine tumors market in the near future. Drugs used for the treatment of rare diseases are known as orphan drugs. Rare diseases affect very small portion of population. Therefore, unlike non-orphan drugs, orphan drugs do not gurantee return on investment. Furthermore, compared to non-orphan drugs, the cost of development of orphan drugs is significantly higher, which is expected to hamper the growth of the neuroendocrine tumors market during the forecast period. 

The global neuroendocrine tumors market can be segmented based on type, treatment, and geography. In terms of type, the market can be divided into merkel cell cancer, neuroendocrine carcinoma, pheochromocytoma, and others. The neuroendocrine carcinoma segment is anticipated to hold a significant share of the neuroendocrine tumors market during the forecast period, as around 60% of neuroendocrine tumor cases pertains to neuroendocrine carcinoma. Based on treatment, the global neuroendocrine tumors market can be calssified into surgery, radiation therapy, and chemotherapy. Surgery is the main treatment prescribed for neuroendocrine tumor. Chemotherapy is a combination of drugs used for the treatment of neuroendocrine tumors. Streptozocin and 5-fluorouracil are examples of drugs used in the treatment of neuroendocrine tumor. Several clinical trials are underway to study new drugs for the treatment of neuroendocrine tumors. Approval or launch of new drugs is expected to drive the neuroendocrine tumors market during the forecast period. However, disappointing results of strong pipeline molecules are expected to restrain the growth of the market. 

Based on geography, the global neuroendocrine tumors market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global neuroendocrine tumors market, followed by Europe. Key drivers of the market in these regions are rising incidence of diseases, developed health care infrastructure, strong clinical pipeline, high level of awareness among people, presence of key market players, and increase in government expenditure. The neuroendocrine tumors market in Asia Pacific is expected to grow rapidly during the forecast period due to large patient base, developing health care infrastructure, and rising government expenditure in health care in the region. Morover, increasing focus of key players for business expansion propels the growth of the neuroendocrine tumors market in Asia Pacific. In Latin America and Middle East & Africa, lack of proper treatment facilities, low income level, and poor patient education are likely to hamper the growth of the neuroendocrine tumors market in the next few years. 

Major players operating in the global neuroendcriens tumors market include F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, Eli Lilly & Company, Novartis AG, Pfizer Ltd., Amgen, Inc., Ispen SA, Teva Pharmaceuticals, Ltd., Callisto Pharmaceuticals Pvt. Ltd., and Biosynthema, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Neuroendocrine Tumors Market

Pre Book